Cargando…

Response to dacomitinib in advanced non-small-cell lung cancer harboring the rare delE709_T710insD mutation: A case report

BACKGROUND: Tyrosine kinase inhibitors (TKI) have been the standard first-line therapy for advanced non-small cell lung cancer (NSCLC) of epidermal growth factor receptor (EGFR) sensitive mutations. Uncommon EGFR mutations are increasingly reported with the development of next-generation sequencing....

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Fei, Xia, Meng-Ling, Pan, Hui-Yun, Pan, Jiong-Wei, Shen, Yi-Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258371/ https://www.ncbi.nlm.nih.gov/pubmed/35979118 http://dx.doi.org/10.12998/wjcc.v10.i17.5916

Ejemplares similares

Great efficacy of afatinib on a patient with lung adenocarcinoma harboring uncommon EGFR delE709_T710insD mutations: a case report
por: An, Ning, et al.
Publicado: (2019)

Afatinib for the treatment of advanced non-small-cell lung cancer harboring an epidermal growth factor receptor exon 18 E709_T710delinsD mutation: a case report
por: Van Acker, Lander, et al.
Publicado: (2021)

Sinus Bradycardia in Carriers of the SCN5A-1795insD Mutation: Unraveling the Mechanism through Computer Simulations
por: Wilders, Ronald
Publicado: (2018)

SCN5A-1795insD founder variant: a unique Dutch experience spanning 7 decades
por: Proost, Virginnio M., et al.
Publicado: (2023)

A Lung Adenocarcinoma Patient With a Rare EGFR E709_T710delinsD Mutation Showed a Good Response to Afatinib Treatment: A Case Report and Literature Review
por: Wei, Yu, et al.
Publicado: (2021)

Functional modulation of atrio-ventricular conduction by enhanced late sodium current and calcium-dependent mechanisms in Scn5a(1798insD/+) mice
por: Rivaud, Mathilde R, et al.
Publicado: (2020)

A real‐world study of dacomitinib in later‐line settings for advanced non‐small cell lung cancer patients harboring EGFR mutations
por: Li, Hong‐Shuai, et al.
Publicado: (2022)

Efficacy and safety of dacomitinib in treatment-naïve patients with advanced NSCLC harboring uncommon EGFR mutation: an ambispective cohort study
por: Pu, Xingxiang, et al.
Publicado: (2023)

Case Report: Dacomitinib Overcomes Osimertinib Resistance in NSCLC Patient Harboring L718Q Mutation: A Case Report
por: Shen, Qian, et al.
Publicado: (2021)

DELE1 tracks perturbed protein import and processing in human mitochondria
por: Fessler, Evelyn, et al.
Publicado: (2022)

Mitochondrial stress is relayed to the cytosol by an OMA1-DELE1-HRI pathway
por: Guo, Xiaoyan, et al.
Publicado: (2020)

Efficacy of dacomitinib in patients with EGFR‐mutated NSCLC and brain metastases
por: Zhang, Jinyao, et al.
Publicado: (2021)

Dacomitinib as a retreatment for advanced non‐small cell lung cancer patient with an uncommon EGFR mutation
por: Morita, Ayako, et al.
Publicado: (2021)

Case Report: Dacomitinib is effective in lung adenocarcinoma with rare EGFR mutation L747P and brain metastases
por: Li, Yibin, et al.
Publicado: (2022)

The Effect of Hepatic Impairment on the Pharmacokinetics of Dacomitinib
por: Piscitelli, Joseph, et al.
Publicado: (2022)

Ubuntu 7.10 Linux: Unleashed
por: Hudson, Andrew, et al.
Publicado: (2008)

Dramatic Response of Brain Metastasis from EGFR-mutation-positive NSCLC to Dacomitinib
por: Kudo, Kenichiro, et al.
Publicado: (2020)

Effects of dacomitinib on the pharmacokinetics of poziotinib in vivo and in vitro
por: Ji, Weiping, et al.
Publicado: (2021)

Sistema procesador de datos IBM/709

Unloading at Cointrin Airport of the IBM 709 computer
por: CERN PhotoLab
Publicado: (1960)

Reference manual 709 Data Processing system
por: International Business Machines. New York
Publicado: (1959)

B709 Mitochondrial Control of Cell Death
por: Kroemer, Guido
Publicado: (2001)

Get Through FRCA Primary – 710 MCQ's
por: Mirakhur, Rajinder K
Publicado: (2006)

Case Report: Dacomitinib May Not Benefit Patients Who Develop Rare Compound Mutations After Later-Line Osimertinib Treatment
por: Li, Hong-Shuai, et al.
Publicado: (2021)

Dacomitinib for Advanced Non-small Cell Lung Cancer Patients Harboring Major Uncommon EGFR Alterations: A Dual-Center, Single-Arm, Ambispective Cohort Study in China
por: Li, Hong-Shuai, et al.
Publicado: (2022)

P418: DELE1 LOSS AND DYSFUNCTIONAL INTEGRATED STRESS SIGNALING IN TP53 MUTATED AML IS A NOVEL PATHWAY FOR VENETOCLAX RESISTANCE
por: Sharon, David, et al.
Publicado: (2023)

Efficacy of dacomitinib in patients with non-small cell lung cancer carrying complex EGFR mutations: a real-world study
por: Li, Hong-Shuai, et al.
Publicado: (2022)

Selezione online di eventi ai collider adronici mediante ricostruzione dele traiettorie di particelle cariche
por: Crescioli, Francesco
Publicado: (2006)

Identification of G-quadruplex structures that possess transcriptional regulating functions in the Dele and Cdc6 CpG islands
por: Bay, Daniyah H., et al.
Publicado: (2017)

Die elektronische Rechenanlage IBM 709 im CERN
Publicado: (1961)

Reference manual 709/7090 Fortran programming system
por: International Business Machines. New York
Publicado: (1958)

BIRICODAR (VX-710; Incel™): an effective chemosensitizer in neuroblastoma
por: Yanagisawa, T, et al.
Publicado: (1999)

Off-line production of intense $^{7,10}Be^{+}$ beams
por: Köster, U, et al.
Publicado: (2002)

Second-line Treatment of Non-Small Cell Lung Cancer: Focus on the Clinical Development of Dacomitinib
por: Zugazagoitia, Jon, et al.
Publicado: (2017)

Non‐small cell lung cancer with EGFR (L858R and E709X) and CNNB1 mutations responded to afatinib
por: Kunishige, Michihiro, et al.
Publicado: (2022)

Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib in Bladder Cancer
por: Tamura, Shuzo, et al.
Publicado: (2018)

Dacomitinib and gedatolisib in combination with fractionated radiation in head and neck cancer
por: Wilson, George D., et al.
Publicado: (2020)

Localization and Accumulation Studies of Dacomitinib in Rat Intestines and Skin by Immunohistochemistry
por: Yamamoto, Yutaro, et al.
Publicado: (2019)

Tumor growth inhibition modeling to support the starting dose for dacomitinib
por: Fostvedt, Luke K., et al.
Publicado: (2022)

Draft Genome Sequence of Necropsobacter rosorum Strain P709(T)
por: Padmanabhan, Roshan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hi47p245rl2dae5sekv7tllmg9